Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jul 9, 2026
- Accession no.
- 0001106578-26-000095
- Filed
- Jul 9, 2026, 9:26 PM ET
- Trade date
- Jul 9, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.24M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $135.42 | +$1,286,490 | 50,013 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −440 | $548.16F2 | −$241,189.08 | 49,573 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −1,536 | $549.01F3 | −$843,272.6 | 48,037 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −1,452 | $550.12F4 | −$798,779.76 | 46,585 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −2,863 | $551.03F5 | −$1,577,610.63 | 43,722 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −1,648 | $552.38F6 | −$910,323.23 | 42,074 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −801 | $553.29F7 | −$443,185.05 | 41,273 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −640 | $554.23F8 | −$354,704.13 | 40,633 | Direct | |
| Jul 9, 2026 | Common Stock | SSaleDisposed | −120 | $555.76F9 | −$66,691.6 | 40,513 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 30,218 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $547.61 to $548.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $548.66 to $549.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $549.69 to $550.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $550.70 to $551.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $551.81 to $552.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $552.84 to $553.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $553.84 to $554.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $555.75 to $555.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.